Enterprise software platform developer SAP intends to offer a personalized treatment option service, in collaboration with MolecularHealth and GATC Biotech, to qualified employees fighting cancer.
The service would be based on MolecularHealths TreatmentMAP software and generate an individual tumor analysis for each patient, providing a clinical interpretation of the clinical and genomic patient data to support their physician in making an individualized treatment decision. In Europe, sequencing data is planned to be provided by GATC Biotech; and in the U.S., MolecularHealth intends to run its own CLIA-certified sequencing lab.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access